Oncolytics Biotech Inc (ONCY) insider trading
Every open-market stock purchase and sale by Oncolytics Biotech Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $363K over the last 12 months (12 buys).
- Last insider buy: Jared Kelly (CEO), $4.8K, 7 months ago.
Last 12 months: insiders bought $363K (12 buys) and sold $0 (0 sales). Last close $0.84 on Jun 4, 2026.
Recent ONCY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 1, 2026 | Jonathan Rigby (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Patricia S Andrews (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Andrew Aromando (C-suite exec) | Bought (not open market) | — |
| Jun 1, 2026 | Deborah Margaret Brown (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Stephen C. Glover (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Allison Hagerman (CTO) | Bought (not open market) | — |
| Jun 1, 2026 | Thomas Charles Heineman (C-suite exec) | Bought (not open market) | — |
| Jun 1, 2026 | Angela Holtham (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Jared Kelly (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | Kirk Look (CFO) | Bought (not open market) | — |
| Jun 1, 2026 | John Bearden McAdory (COO) | Bought (not open market) | — |
| Jun 1, 2026 | Bernd R. Seizinger (Director) | Bought (not open market) | — |
| Jun 1, 2026 | James T. Parsons (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Wayne Pisano (Director) | Bought (not open market) | — |
| Mar 12, 2026 | Jared Kelly (CEO) | Bought | $4.8K |
| Mar 11, 2026 | James T. Parsons (Director) | Bought | $10.3K |
| Feb 12, 2026 | Bernd R. Seizinger (Director) | Bought | $33.9K |
| Feb 12, 2026 | Patricia S Andrews (Director) | Bought | $30.3K |
| Feb 12, 2026 | Wayne Pisano (Director) | Bought | $25.3K |
| Feb 12, 2026 | Jared Kelly (CEO) | Bought | $24.8K |
| Feb 12, 2026 | Deborah Margaret Brown (Director) | Bought | $21.2K |
| Feb 12, 2026 | Kirk Look (CFO) | Bought | $10.1K |
| Feb 12, 2026 | Thomas Charles Heineman (C-suite exec) | Bought | $10K |
| Feb 12, 2026 | Allison Hagerman (VP) | Bought | $8.3K |
| Feb 11, 2026 | Bernd R. Seizinger (Director) | Bought | $49.6K |
Who's trading ONCY
- Patricia S Andrews, Director: bought $30.3K (1 buy), last Jun 1, 2026
- Andrew Aromando, C-suite exec: bought $25.4K (1 buy), last Jun 1, 2026
- Deborah Margaret Brown, Director: bought $21.2K (1 buy), last Jun 1, 2026
- Stephen C. Glover, Director: other filings, last Jun 1, 2026
- Allison Hagerman, CTO: bought $8.3K (1 buy), last Jun 1, 2026
- Thomas Charles Heineman, C-suite exec: bought $10K (1 buy), last Jun 1, 2026
- Angela Holtham, Director: other filings, last Jun 1, 2026
- Jared Kelly, CEO: bought $34.4K (3 buys), last Jun 1, 2026
- Kirk Look, CFO: bought $10.1K (1 buy), last Jun 1, 2026
- John Bearden McAdory, COO: other filings, last Jun 1, 2026
- James T. Parsons, Director: bought $10.3K (1 buy), last Jun 1, 2026
- Wayne Pisano, Director: bought $25.3K (1 buy), last Jun 1, 2026
- Jonathan Rigby, Director: other filings, last Jun 1, 2026
- Bernd R. Seizinger, Director: bought $187K (3 buys), last Jun 1, 2026
Get free alerts when an insider at Oncolytics Biotech Inc files a new trade →